NM_033056.4:c.1917+33_1917+34dupGT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_033056.4(PCDH15):​c.1917+33_1917+34dupGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 1,470,580 control chromosomes in the GnomAD database, including 7,105 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 1897 hom., cov: 0)
Exomes 𝑓: 0.14 ( 5208 hom. )

Consequence

PCDH15
NM_033056.4 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0900

Publications

2 publications found
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
PCDH15 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 23
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-54132840-T-TAC is Benign according to our data. Variant chr10-54132840-T-TAC is described in ClinVar as Benign. ClinVar VariationId is 227007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH15NM_033056.4 linkc.1917+33_1917+34dupGT intron_variant Intron 15 of 32 ENST00000320301.11 NP_149045.3 Q96QU1-1
PCDH15NM_001384140.1 linkc.1917+33_1917+34dupGT intron_variant Intron 15 of 37 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkc.1917+34_1917+35insGT intron_variant Intron 15 of 32 1 NM_033056.4 ENSP00000322604.6 Q96QU1-1
PCDH15ENST00000644397.2 linkc.1917+34_1917+35insGT intron_variant Intron 15 of 37 NM_001384140.1 ENSP00000495195.1 A0A2R8Y6C0

Frequencies

GnomAD3 genomes
AF:
0.156
AC:
23468
AN:
150306
Hom.:
1894
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.193
Gnomad AMI
AF:
0.224
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.133
Gnomad EAS
AF:
0.288
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.0878
Gnomad MID
AF:
0.119
Gnomad NFE
AF:
0.128
Gnomad OTH
AF:
0.168
GnomAD2 exomes
AF:
0.198
AC:
27706
AN:
140090
AF XY:
0.191
show subpopulations
Gnomad AFR exome
AF:
0.214
Gnomad AMR exome
AF:
0.312
Gnomad ASJ exome
AF:
0.190
Gnomad EAS exome
AF:
0.342
Gnomad FIN exome
AF:
0.126
Gnomad NFE exome
AF:
0.166
Gnomad OTH exome
AF:
0.197
GnomAD4 exome
AF:
0.137
AC:
180874
AN:
1320168
Hom.:
5208
Cov.:
31
AF XY:
0.136
AC XY:
89074
AN XY:
653880
show subpopulations
African (AFR)
AF:
0.186
AC:
5640
AN:
30308
American (AMR)
AF:
0.245
AC:
8960
AN:
36632
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
3317
AN:
23658
East Asian (EAS)
AF:
0.339
AC:
9688
AN:
28612
South Asian (SAS)
AF:
0.108
AC:
8116
AN:
75202
European-Finnish (FIN)
AF:
0.0982
AC:
4690
AN:
47736
Middle Eastern (MID)
AF:
0.154
AC:
832
AN:
5388
European-Non Finnish (NFE)
AF:
0.129
AC:
131359
AN:
1017678
Other (OTH)
AF:
0.151
AC:
8272
AN:
54954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
8456
16912
25368
33824
42280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5094
10188
15282
20376
25470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.156
AC:
23497
AN:
150412
Hom.:
1897
Cov.:
0
AF XY:
0.156
AC XY:
11459
AN XY:
73422
show subpopulations
African (AFR)
AF:
0.193
AC:
7908
AN:
40962
American (AMR)
AF:
0.199
AC:
2999
AN:
15096
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
460
AN:
3446
East Asian (EAS)
AF:
0.288
AC:
1463
AN:
5074
South Asian (SAS)
AF:
0.109
AC:
520
AN:
4762
European-Finnish (FIN)
AF:
0.0878
AC:
906
AN:
10320
Middle Eastern (MID)
AF:
0.120
AC:
35
AN:
292
European-Non Finnish (NFE)
AF:
0.128
AC:
8648
AN:
67476
Other (OTH)
AF:
0.171
AC:
356
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
960
1919
2879
3838
4798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.100
Hom.:
79

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 08, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1917+13GT[12] in intron 15 of PCDH15: This variant is not expected to have cli nical significance because it is not located within the splice consensus sequenc e. It has been detected in 17.5% (8259/47276) of chromosomes across several dive rse populations by the Exome Aggregate Consortium (http://exac.broadinstitute.or g/variant/10-55892600-T-TAC). -

not provided Benign:1
Aug 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.090
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5785040; hg19: chr10-55892600; API